Skip to main content

David BolosMD, MS

Program Director, Fellowship in Hematology and Medical Oncology, Olive View-UCLA Medical Center

Assistant Clinical Professor Health Sciences, David Geffen School of Medicine at the University of California, Los Angeles


Specialty: Hematology and Medical Oncology

Background: Dr. David Bolos is a board-certified hematologist and oncologist. He treats all patients with solid tumors and hematologic conditions, with a particular interest in hematologic malignancies, LGBTQIA+ health, medical education, quality improvement, and treating the underserved. He is also active in projects focused on medical education, quality of care, and improved access to care for cancer patients.

Dr. David Bolos received his M.S. in Chemistry from Loyola University Chicago and his M.D. from The Chicago Medical School at Rosalind Franklin University of Medicine & Science. He subsequently moved to the West Coast and completed Internal Medicine residency at the University of California, Los Angeles followed by Hematology-Oncology fellowship training at the UCLA-Olive View / Cedars-Sinai / Kaiser Los Angeles program. He then stayed on as faculty at UCLA-Olive View Medical Center. He is board certified in Internal Medicine, Hematology, and Medical Oncology. He is currently the Program Director of the Hematology/Oncology Fellowship.

Research Interests:
Medical Education
Hematologic Malignancies
Access to Care
Quality Improvement
LGBTQIA+ Health

Education:
M.D., The Chicago Medical School at Rosalind Franklin University, 2012
Internal Medicine Residency, UCLA Ronald Reagan Medical Center, 2012-2015
Hematology and Medical Oncology Fellowship, Olive View-UCLA Medical Center, 2015-2018

Committees & Administrative Duties:
Department of Medicine Hematology/Oncology Peer Review Committee
Internal Medicine Residency Curriculum Committee Member
Hematology/Oncology Fellowship CCC Committee
Fellowship Research Mentoring Advisor
Facility Reviewer, Non-formulary Pharmacy Requests
Multidisciplinary Tumor Board Advisor and Presenter
Quality Improvement Officer for Hematology/Oncology Division
Prior Authorization Reviewer for Department of Hematology/Oncology
Hematology/Oncology Department Utilization Management Reviewer
Olive View UCLA Medical Center LGBTQIA+ Committee Member

Recent Publications & Projects:
Lai S, Doan TN, Bolos D. “Common Variable Immunodeficiency (CVID) in a Treated Lymphoma Patient. Which came first, the Lymphoma or the CVID?” The Proceedings of UCLA., May 2022

Ai A, Bhardwaj S, Bolos D. “Peripartum Hemophagocytic Lymphohistiocytosis (HLH).” The Proceedings of UCLA. 5/2022

Tareen S A, Rodriguez J, Bolos D. Retrospective Analysis of HER2+ Breast Cancer Outcomes at a County Hospital: Do Published Outcomes Hold up in the Real World?. Cureus 12(5): e7937. doi:10.7759/cureus.7937, May 02, 2020

Ochoa F, Miller J, Bolos D. Society of General Internal Medicine Poster: “Splenomegaly and Headache in a 27 Year Old Man.”. Olive View Medical Center Jan 2019.

Kumar D, Bolos D. Solomon Scholars Research Poster: “Not Your Average Inflammatory Bowel Disease: A Lymphoproliferative Bloody Diarrhea.”. Olive View Medical Center 2018

Kumar D, Bolos D. “Not Your Average Inflammatory Bowel Disease: A Lymphoproliferative Bloody Diarrhea.” Cancer Biology and Therapy. In Editorial Review. 2019

Pham PC, Reddy P, Qaqish S, Kamath A, Rodriguez J, Bolos D, Zalom M. “Cisplatin-Induced Renal Salt Wasting Requiring over 12 Liters of 3% Saline Replacement”. Case Reports in Nephrology, Volume 2017 (2017), Article ID 8137078

Tabatabai R, Linhares Y, Bolos D, Mita M. “Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics”; Target Oncol. 2017 Jun 26. doi: 10.1007/s11523-017-0507-4

Rodriguez J, Bolos D, Zalom M. American College of Physicians Poster: “Cisplatin Salt Wasting”, Olive View Medical Center 2016-2017

Cerk B, Bolos D, Zalom M. Solomon Scholars Research Poster: “Searching for Secondary Causes of HLH” Olive View Medical Center 2016-2017

Bolos D, Solomon Scholars Research Poster: “Systemic Therapies in Hepatocellular Carcinoma”, UCLA Medical Center, 2015

Milin A, Bolos D, American College of Physicians Poster: “Not Your Typical Pox: A Dramatic Presentation of Fulminant Hepatitis”, UCLA Medical Center 2015-2016

Bolos D, Finn R. “Systemic Therapy in HCC: Lessons from Brivanib”, J Hepatology. 2014 Oct;61(4):947-50. doi: 10.1016/j.jhep.2014.06.019. Epub 2014 Jun 24

Interests:
Cats
Aquariums
Museums
Cooking
Gardening
TV/Movies